Navigation Links
Covidien Announces New Source of Vital Medical Isotopes
Date:2/17/2010

WARSAW, Poland, February 17, 2010 /PRNewswire-FirstCall/ --

- Addition of Polish Research Reactor Helps With Worldwide Supply Shortage

Covidien (NYSE: COV), a leading global provider of healthcare products, and the Institute of Atomic Energy in Poland (IAE POLATOM) today announced an agreement to augment and further diversify Covidien's supply of Molybdenum 99 (Mo 99) to produce the medical isotope Technetium 99m (Tc 99m).

Tc 99m is a vital medical isotope used in over 80 percent of all nuclear medicine diagnostic and functional studies of organs and anatomical systems. The information from these studies is used by many medical specialists (including radiologists, nephrologists, oncologists and cardiologists) to better diagnose and treat patients. More than 35 million nuclear medicine procedures are performed worldwide each year, more than half in the United States.

Adding the IAE POLATOM'S Maria Research Reactor to Covidien's global supply chain is expected to help Covidien meet the needs of more than one million additional patients in just the first six months after the reactor begins supplying Mo 99.

"This is an historic agreement. It is the first time in decades that a new reactor has been brought into the global supply chain for medical isotopes," said Timothy R. Wright, President, Pharmaceuticals, Covidien. "We are excited that we will now be working together to provide more than a million patients around the globe with access to a critical medical isotope during this serious shortage."

The announcement comes two days before the High Flux Reactor (HFR) in Pett
'/>"/>

SOURCE Covidien
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Frost & Sullivan Recognizes Covidien for Its CT Contrast Delivery System With RFID Enabled Intelligence
2. Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2009 Financial Results Teleconference and Webcast
3. Encorium Group, Inc. Announces One-for-Eight Reverse Stock Split
4. GenomeQuest Announces Boston Seminar: Sequence Data Management for Next Generation Sequencing
5. CoAxia Announces Completion of Enrollment in Ischemic Stroke Trial
6. 3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results
7. Kendle Announces Details Regarding Fourth Quarter and Full-Year 2009 Earnings Conference Call and Webcast
8. Moleac Announces Breakthrough Results on Neuroprotective and Neurogenerative Properties of NeuroAiD
9. Intellect Neurosciences, Inc. Announces Preliminary Agreement with Significant Shareholders to Provide Interim Funding and Assist the Company in Efforts to Secure Additional Financing
10. Kinexus Announces the Launch of a New Protein Kinase Microarray
11. Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... A major challenge before new biotechnology start-up ... of Boston-Cambridge, is gaining visibility that can lead to ... Director of Boston’s Adult Stem Cell Technology Center, LLC ... of his company an important priority since he started ... a social media marketing campaign launched earlier ...
(Date:8/28/2014)... “This kit has an improved extraction efficiency and provides ... ppb,” said Mark Tess, PhD, Mycotoxin Product Manager for Charm ... and USDA-GIPSA inspection agencies that have a need to detect ... in a matter of minutes with nothing but our equipment ... and grain before accepting it, but they no longer have ...
(Date:8/28/2014)... , Aug. 28, 2014  Next month, executives from clinical ... key industry events beginning with Patient-Centered Clinical Trials 2014 ... Boston , September 4-5. Patient recruitment experts ... Aaron Fleishman will share insights on the benefits ... variety of tactics – from media to mobile apps – ...
(Date:8/28/2014)... USA (PRWEB) August 27, 2014 Scientists, ... month for SPIE Laser Damage 2014 symposium. ... materials for high-power lasers will run 14-17 September. The ... for optics and photonics . , The premier conference ... understanding laser damage to optical materials will engage researchers ...
Breaking Biology Technology:The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 3The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 4BBK Worldwide Leads Sessions at Key September Events 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 3
... Mass., Jan. 6, 2011 GENFIT (Alternext: ALGFT; ISIN: ... discovery and development, focusing on the early diagnosis and ... its presence at two U.S. events: the 28th J.P. ... and the Biotech Showcase (from January 10th to 12th, ...
... 2011 Verenium Corporation (Nasdaq: VRNM ), ... industrial enzyme solutions, today announced that the ... has been dismissed.  Verenium,s motion for summary judgment to ... District Court for the Southern District of New York. ...
... CARLSBAD, Calif., Jan. 6, 2011 Isis Pharmaceuticals, Inc. ... has added two new drugs to its development pipeline, ... to treat obesity by increasing metabolism, particularly by increasing ... of fibroblast growth factor receptor 4 (FGFR4) in the ...
Cached Biology Technology:GENFIT: Strong U.S. Exposure for Its Biomarker Activity 2GENFIT: Strong U.S. Exposure for Its Biomarker Activity 3Verenium Announces Favorable Outcome of Capital Ventures International Lawsuit 2Verenium Announces Favorable Outcome of Capital Ventures International Lawsuit 3Isis Pharmaceuticals Adds Two New Drugs to Development Pipeline 2Isis Pharmaceuticals Adds Two New Drugs to Development Pipeline 3Isis Pharmaceuticals Adds Two New Drugs to Development Pipeline 4
(Date:8/28/2014)... a significant health risk to people with asthma according to ... and Clinical Immunology . , By critically reviewing the findings ... found that the presence of several types of mould can ... increasing the likelihood of developing the condition. , The research ... Exeter Medical School and is the first time all of ...
(Date:8/28/2014)... Munich have assigned a number of 435-million-year-old fossils ... animals lived in shallow marine habitats and were ... Jurassic strata. , Before they sank to ... were fossilized some 435 million years ago, these ... seas although they were not exactly inconspicuous, ...
(Date:8/27/2014)... North America,s megafauna mastodons, short-faced bears, giant ground ... disappeared close to 13,000 years ago at the end ... extinction has long been debated by scientists who, until ... group of scientists, including UC Santa Barbara,s James Kennett, ... that a comet collision with Earth played a major ...
Breaking Biology News(10 mins):Indoor mold poses health risk to asthma sufferers 2Paleontology: Oldest representative of a weird arthropod group 2Nanodiamonds are forever 2Nanodiamonds are forever 3
... away at the problem of antibiotic resistance now have ... target in bacteria evolves to become resistant to some ... new experimental antibiotics that are being engineered to circumvent ... Led by Thomas A. Steitz, a Howard Hughes Medical ...
... as disturbance makes a landscape susceptible to invasion by ... globe could be contributing to the accelerating spread of ... the June 2005 issue of BioScience. John A. Havel ... and M. Jake Vander Zanden of the University of ...
... ever covered a flashlight with your hand and seen the ... light in the therapeutic window ?that magic wavelength that is ... they can use light at that wavelength to signal manmade ... , Such possibilities will be discussed in a poster and ...
Cached Biology News:Researchers make gains in understanding antibiotic resistance 2Researchers make gains in understanding antibiotic resistance 3Reservoirs may accelerate the spread of invasive aquatic species, researchers say 2Medical molecules designed to respond to visible light that can penetrate tissue 2
Mouse monoclonal [2A4] to Cytokeratin 8 + 18 + 19 ( Abpromise for all tested applications). Antigen: Cytokeratins isolated from cultured pig kidney epithelial cells. Entrez GeneID: 3856 S...
Tube-O-DIALYZER Floats, small....
Nestin, Human...
Rabbit polyclonal to Survivin DEx3 ( Abpromise for all tested applications). entrezGeneID: 332 SwissProtID: O15392...
Biology Products: